 |
|
| Blog results | Results 1 - 10 of about 450 for keppra antiepileptic. (0.28 seconds) |
| Sorted by relevance Sort by date |
| 11 Dec 2009 by Liz Jones Levetiracetam Tablets are the generic version of UCB Pharma's antiepileptic Keppra®. This additional strength of Levetiracetam Tablets complements Mylan's already approved and marketed strengths of 250 mg, 500 mg and 750 mg. ... Press Releases - http://www.fiercebiotech.com/press-releases |
| 12 Dec 2009 ... final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets, 1000 mg. Levetiracetam Tablets are the generic version of UCB Pharma's antiepileptic Keppra®... Pharmainfo.net - Regulatory and Drug Approvals... - http://www.pharmainfo.net/taxonomy/term/2923/0 |
| 11 Dec 2009 Mylan Receives Approval for Generic Version of Antiepileptic Keppra(R) 1000 mg. Advertisement: read more. Pharmainfo.net - http://www.pharmainfo.net/ |
| 4 May 2009 Levetiracetam (marketed as Keppra) Oxcarbazepine (marketed as Trileptal) Pregabalin (marketed as Lyrica) Tiagabine (marketed as Gabitril) Topiramate (marketed as Topamax) Valproate (marketed as Depakote, Depakote ER, Depakene, Depacon) ... Drugs.com - FDA MedWatch Alerts - http://www.drugs.com/fda_alerts.html - References [ More results from Drugs.com - FDA MedWatch Alerts ] |
| 12 Dec 2009 by Zamp Mylan Inc. (NASDAQ: MYL) announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets, 1000 mg. ... Bio Topics - http://biotopics.zampbioworld.org/ |
| 12 Dec 2009 by Health-Care-International Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the US Food and Drug Administration for its Abbreviated New Drug Application for Levetiracetam Tablets, 1000 mg. 7 Vote(s) HealthCare International / Health Care News Blogs - http://www.healthcareinternational.net/ |
| 12 Dec 2009 by MedicalReplies Mylan Inc. (NASDAQ: MYL) announced that its subsidiary Mylan Pharmaceuticals Inc. Medical Replies - Medical News And Articles - http://medicalreplies.com/ |
| 15 Jan 2010 by admin The exact mechanism by which Keppra exerts its antiepileptic effect is not known and does not appear to derive from any interaction with mechanisms known to be involved in inhibitory and excitatory neurotransmission. ... Health and Pills - http://healthandpills.com/ |
| 12 Dec 2009 by admin Mylan Inc. (NASDAQ: MYL) announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the US. The rest is here: Mylan Receives Approval For Generic Version Of Antiepileptic Keppra® 1000 Mg. Get Some News - http://getsomenews.com/ |
| 17 Dec 2009 by pillscribe The approved anti-epileptic drugs affected by these safety label changes are Carbatrol, Celontin, Depakene, Depakote ER, Depakote sprinkles, Depakote tablets, Dilantin, Equetro, Felbatol, Gabitril, Keppra, Keppra XR, Klonopin, Lamictal, ... DWS Pill Scribe - http://www.dancewithshadows.com/pillscribe/ [ More results from DWS Pill Scribe ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
